Shalom Madar

Did experimental biology die? Lessons from 30 years of p53 research.

Shalom Madar, Ido Goldstein, Varda Rotter, 2009, Cancer research.

Mutant p53 gain of function is interwoven into the hallmarks of cancer

Shalom Madar, Varda Rotter, V. Rotter, 2011, The Journal of pathology.

p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation

Shalom Madar, Ido Goldstein, Varda Rotter, 2008, Molecular systems biology.

A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype

Shalom Madar, Ido Goldstein, Varda Rotter, 2010, PloS one.

Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53.

Shalom Madar, Ido Goldstein, Varda Rotter, 2013, Carcinogenesis.

p53, a novel regulator of lipid metabolism pathways

Shalom Madar, Ido Goldstein, Varda Rotter, 2012, BMC Proceedings.

'Cancer associated fibroblasts'--more than meets the eye.

Shalom Madar, Ido Goldstein, Varda Rotter, 2013, Trends in molecular medicine.

Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature

Shalom Madar, Ido Goldstein, Varda Rotter, 2012, Journal of Cell Science.